Announcing New COV-Denominated Margin Trading And Copy Trading Accounts 

We are proud to reveal that our close partner Copy Trading is proceeding with the latest milestone within their product roadmap and have delivered yet another valuable addition to the many features the COV token provides.

Last year, together, we enabled a COV wallet that could be used to activate Advanced, Premium, and Elite account memberships, each with a plethora of COV token utilities that could be activated. Utilities include a profit share increase, improved following limits, trading fee discounts, and more.

Today we are happy to introduce the latest Copy Trading update: the launch of COV-denominated margin trading accounts and copy trading strategy manager accounts. This means that the Copy Trading community can now use their COV tokens to trade the full lineup of world-class trading instruments without the need to first exchange COV into BTC, ETH, or another asset.

All-New COV-Denominated Accounts Explained

To assist the Copy Trading community with taking advantage of these new COV-denominated account types, we’ve prepared the below guides along with further details about the benefits they provide.

COV-Denominated Strategy Manager Account & Following Walkthrough

Creating a COV-denominated strategy manager account is as easy as setting up an account with any other asset.

Announcing New COV-Denominated Margin Trading And Copy Trading Accounts  - PrimeXBT 1

  • Step 1: Simply visit the copy-trading section of PrimeXBT and click “Get started” within the My Strategies tab. 
  • Step 2: Next, choose COV as a currency, and fill out the rest of the remaining information related to the strategy.
  • Step 3: Begin trading and gaining followers.

In a future roadmap update, strategy managers will enjoy a 25% revenue share from all profits generated for followers compared to the standard 20%, regardless of membership tier. The planned increased revenue share can boost profitability for skilled strategy managers.

Announcing New COV-Denominated Margin Trading And Copy Trading Accounts  - PrimeXBT 4

Followers can also follow COV-denominated strategies using the COV token. A future roadmap update will enable those that take advantage and follow COV-denominated strategies to benefit from the maximum 75% profit share instead of the standard 65%.

These exciting roadmap updates and further COV token utility improvements from Copy Trading will be revealed in the coming months.

COV-Denominated Margin Trading Account Walkthrough

PrimeXBT users can also now utilize COV tokens as collateral to fund a margin trading account, much like you can with BTC, ETH, USDT, and USDC. COV tokens provide PrimeXBT users with yet another alternative asset for the greatest possible flexibility and to further support our partner Copy Trading’s development roadmap.

Setting up a COV-denominated margin trading account is as easy as any other asset.

Announcing New COV-Denominated Margin Trading And Copy Trading Accounts  - PrimeXBT 2

  • Step 1: Select COV as the currency when creating a new margin trading account.
  • Step 2: Move COV from the wallet to fund the margin trading account.
  • Step 3: Select a market and begin trading.

Platform users can then manage their positions by selecting the COV margin account specifically from the margin section dropdown.

Announcing New COV-Denominated Margin Trading And Copy Trading Accounts  - primexbt 3

All-New COV-Denominated Accounts Are Now Live

The new COV-denominated account updates from Copy Trading are now live for PrimeXBT users.  The Copy Trading roadmap also includes the aforementioned profit share improvements for strategy managers and followers.

Be sure to keep checking the official PrimeXBT and Copy Trading blog for additional details when they are available.

Alert TriangleRisk Disclaimer
Disclaimer: The information provided does not constitute, in any way, a solicitation or inducement to buy or sell any of our products.
Any material presented under this section of our website is not intended and should not be considered investment research or investment advice. Any Comments and analysis reflect the views of different external and internal analysts at any given time and are subject to change...
Disclaimer: The information provided does not constitute, in any way, a solicitation or inducement to buy or sell any of our products.
Any material presented under this section of our website is not intended and should not be considered investment research or investment advice. Any Comments and analysis reflect the views of different external and internal analysts at any given time and are subject to change at any time. The recipient acknowledges that he/she is solely responsible for any trading decisions taken.

Risk warning: Our products are complex financial instruments which come with a high risk of losing money rapidly due to leverage. These products are not suitable for all investors. You should consider whether you understand how leveraged products work and whether you can afford to take the inherently high risk of losing your money. If you do not understand the risks involved, or if you have any questions regarding our products, you should seek independent financial and/or legal advice if necessary. Past performance of a financial product does not prejudge in any way their future performance.

Other news

Ready to put your insights into action?

Receive the latest news and stay informed.

Start Trading Start Trading
Start Trading

Got questions? Visit our Help Centre

Risk Warning:

Risk Warning: Trading in leveraged products carries a high level of risk and may not be suitable for all investors.